Latest VR Adviser, LLC Stock Portfolio
$2.68Billion– No. of Holdings #33
VR Adviser, LLC Performance:
2026 Q1: 22.02%YTD: 22.02%2025: 58.45%
Performance for 2026 Q1 is 22.02%, and YTD is 22.02%, and 2025 is 58.45%.
About VR Adviser, LLC and 13F Hedge Fund Stock Holdings
VR ADVISER, LLC is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, VR ADVISER, LLC reported an equity portfolio of $2.7 Billions as of 31 Mar, 2026.
The top stock holdings of VR ADVISER, LLC are , ERAS, . The fund has invested 26.7% of it's portfolio in APOGEE THERAPEUTICS INC and 9.9% of portfolio in ERASCA INC.
The fund managers got completely rid off UPSTREAM BIO INC stocks. They significantly reduced their stock positions in ENLIVEN THERAPEUTICS INC, CYTOMX THERAPEUTICS INC (CTMX) and ORIC PHARMACEUTICALS INC (ORIC). VR ADVISER, LLC opened new stock positions in DAMORA THERAPEUTICS INC (GLTO), RELMADA THERAPEUTICS INC (RLMD) and TENAX THERAPEUTICS INC (TENX). The fund showed a lot of confidence in some stocks as they added substantially to VOR BIOPHARMA INC (VOR), OCULAR THERAPEUTIX INC (OCUL) and ZURA BIO LTD.
The top stock holdings of VR ADVISER, LLC are , ERAS, . The fund has invested 26.7% of it's portfolio in APOGEE THERAPEUTICS INC and 9.9% of portfolio in ERASCA INC.
The fund managers got completely rid off UPSTREAM BIO INC stocks. They significantly reduced their stock positions in ENLIVEN THERAPEUTICS INC, CYTOMX THERAPEUTICS INC (CTMX) and ORIC PHARMACEUTICALS INC (ORIC). VR ADVISER, LLC opened new stock positions in DAMORA THERAPEUTICS INC (GLTO), RELMADA THERAPEUTICS INC (RLMD) and TENAX THERAPEUTICS INC (TENX). The fund showed a lot of confidence in some stocks as they added substantially to VOR BIOPHARMA INC (VOR), OCULAR THERAPEUTIX INC (OCUL) and ZURA BIO LTD.
VR Adviser, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
VR Adviser, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Venrock Adviser, LLC made a return of 22.02% in the last quarter. In trailing 12 months, it's portfolio return was 150.99%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| damora therapeutics inc | 93,333,100 |
| relmada therapeutics inc | 33,709,900 |
| tenax therapeutics inc | 26,787,400 |
| adlai nortye ltd | 22,232,100 |
| century therapeutics inc | 19,652,200 |
| korro bio inc | 11,427,500 |
| alto neuroscience inc | 11,240,000 |
| x4 pharmaceuticals inc | 1,365,070 |
New stocks bought by VR Adviser, LLC
Additions
| Ticker | % Inc. |
|---|---|
| vor biopharma inc | 56.49 |
| ocular therapeutix inc | 41.44 |
| zura bio ltd | 20.39 |
| dianthus therapeutics inc | 18.00 |
| maze therapeutics inc | 3.45 |
| cybin inc | 0.3 |
Additions to existing portfolio by VR Adviser, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| enliven therapeutics inc | -46.49 |
| cytomx therapeutics inc | -35.85 |
| oric pharmaceuticals inc | -23.9 |
| septerna inc | -17.15 |
| erasca inc | -8.26 |
| kalvista pharmaceuticals inc | -3.78 |
VR Adviser, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| upstream bio inc | -31,746,400 |
| casi pharmaceuticals inc | -839,170 |
VR Adviser, LLC got rid off the above stocks
Sector Distribution
Venrock Adviser, LLC has about 50.4% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 50.4 |
| Others | 49.6 |
Market Cap. Distribution
Venrock Adviser, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
- NANO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 49.6 |
| MID-CAP | 24 |
| SMALL-CAP | 17.2 |
| MICRO-CAP | 5.8 |
| NANO-CAP | 3.5 |
Stocks belong to which Index?
About 35.3% of the stocks held by Venrock Adviser, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 64.7 |
| RUSSELL 2000 | 35.3 |
VR Adviser, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of VR Adviser, LLC
Venrock Adviser, LLC has 33 stocks in it's portfolio. About 72.1% of the portfolio is in top 10 stocks. VRDN proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for Venrock Adviser, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGLE | spyre therapeutics inc | 6.94 | 3,685,450 | 185,894,000 | unchanged | 0.00 | ||
| AVTE | jade biosciences inc | 1.69 | 3,220,360 | 45,246,100 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics inc | 0.73 | 1,379,960 | 19,609,300 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 2.87 | 2,000,000 | 76,980,000 | unchanged | 0.00 | ||
| CTMX | cytomx therapeutics inc | 1.75 | 9,982,120 | 46,916,000 | reduced | -35.85 | ||
| CYBN | cybin inc | 0.69 | 3,851,650 | 18,487,900 | added | 0.3 | ||
| DYN | dyne therapeutics inc | 1.47 | 2,173,910 | 39,413,000 | unchanged | 0.00 | ||
| ERAS | erasca inc | 9.89 | 16,382,800 | 265,074,000 | reduced | -8.26 | ||
| GLTO | damora therapeutics inc | 3.48 | 3,603,600 | 93,333,100 | new | |||
| IPSC | century therapeutics inc | 0.73 | 8,695,650 | 19,652,200 | new | |||
| KALV | kalvista pharmaceuticals inc | 4.86 | 6,474,480 | 130,331,000 | reduced | -3.78 | ||
| OCUL | ocular therapeutix inc | 3.27 | 10,346,900 | 87,638,500 | added | 41.44 | ||
| ORIC | oric pharmaceuticals inc | 2.04 | 4,319,760 | 54,731,400 | reduced | -23.9 | ||
| RLMD | relmada therapeutics inc | 1.26 | 4,843,380 | 33,709,900 | new | |||
| SRZN | surrozen inc | 0.69 | 632,931 | 18,437,300 | unchanged | 0.00 | ||
| SVRA | savara inc | 2.80 | 13,740,400 | 75,022,400 | unchanged | 0.00 | ||
| TENX | tenax therapeutics inc | 1.00 | 1,675,260 | 26,787,400 | new | |||
| VOR | vor biopharma inc | 2.02 | 3,041,720 | 54,264,300 | added | 56.49 | ||
| VRDN | viridian therapeutics inc | 2.84 | 3,882,710 | 75,945,800 | unchanged | 0.00 | ||
| XFOR | x4 pharmaceuticals inc | 0.05 | 330,525 | 1,365,070 | new | |||